Taken together, these studies indicate that the balance of AMPK signaling must be modulated very carefully; while increased signaling may lead to better immune cell survival and reduce flux through glycolytic pathway in cancer cells (74), it can also contribute to reducing the effects of cell stress signaling which can lead to tumor cell survival. This evidence concerns the gene PRKAA1 and neoplasm.